Identification of metabolic bone disease in patients with endogenous hyperthyroidism: Role of biological markers of bone turnover

Calcified Tissue International

Volumn 61, Issue 5, 1997, Pages 370-376

  Jodar Gimeno E ^a,c   Munoz Torres M ^a   Escobar Jimenez F ^a   Quesada Charneco, M ^a   Luna Del Castillo, J D ^b   Olea N ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b University of Medicine   (Spain)

^c NONE   (Spain)

Author keywords

Bone mineral density; Bone turnover markers; Dual X ray absorptiometry; Hyperthyroidism; Osteoporosis prediction

Indexed keywords

ALKALINE PHOSPHATASE; ALKALINE PHOSPHATASE BONE ISOENZYME; COLLAGEN TYPE 1; HYDROXYPROLINE; OSTEOCALCIN;

ARTICLE; BONE DENSITY; BONE TURNOVER; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; HUMAN; HYDROXYPROLINE URINE LEVEL; HYPERTHYROIDISM; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PREDICTION; PRIORITY JOURNAL;

ACID PHOSPHATASE; ADULT; ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; BONE DENSITY; BONE DISEASES, METABOLIC; BONE REMODELING; DENSITOMETRY, X-RAY; FEMALE; FEMUR NECK; HUMANS; HYDROXYPROLINE; HYPERTHYROIDISM; ISOENZYMES; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; OSTEOPOROSIS; PEPTIDE FRAGMENTS; PROCOLLAGEN; THYROTROPIN;

EID: 0342327313     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002239900350     Document Type: Article

References (23)

1. von Recklinghausen F (1981) Die fibrose oder deformirende Ostitis, die Osteomalazie und die Osteoplastiche Carzinose, in ihren gegenseitigen Beziehungen. In: Reimer G (ed) Festschrift Rudolf Virchow. Berlin, pp 1-89
2. Melsen F, Mosekilde L (1977) Morphometric and dynamic studies of bone changes in hyperthyroidism. Acta Path Microbiol Scand 85:141-150
3. Campos Pastor MM, Muñoz-Torres M, Escobar-Jiménez F, Ruiz de Almodovar N, Jódar E (1993) Bone mass in females with different thyroid disorders: influence of menopausal status. Bone Miner 21:1-8
4. Wakasugi M, Wakao R, Tawata M, Gan N, Koizumi K, Onaya T (1993) Bone mineral density in patients with hyperthyroidism measured by dual X-ray absorptiometry. Clin Endocrinol 38:283-286
5. Riggs BL, Melton III LJ (1992) The prevention and treatment of osteoporosis. New Engl J Med 327:620-627
6. 47Ca-kinetics. Efficiency of serum bone gamma-carboxyglutamic acid-containing protein, serum alkaline phosphatase, and urinary hydroxyproline excretion. J Clin Invest 76:2254-2258
7. Garnero P, Vassy V, Bertholin A, Riou JP, Delmas PD (1994) Markers of bone turnover in hyperthyroidism and the effects of the treatment. J Clin Endocrinol Metab 78:955-959
8. Spector TD, Edwards AC, Thompson PW (1992) Use of a risk factor and dietary questionnaire in predicting bone density and subsequent bone loss at menopause. Ann Rheum Dis 51: 1252-1253
9. Christiansen C, Rodbro P, Riis BJ (1987) Prediction of rapid bone loss in postmenopausal women. Lancet 1:1105-1108
10. Christiansen C, Riis BJ, Rodbro P (1990) Screening procedure for women at risk of developing postmenopausal osteoporosis. Osteoporosis Int 1:35-40
11. Slemenda CW, Hui SL, Longscope C. Wellman H, Johnston CC (1990) Predictors of bone mass in perimenopausal women: a prospective study of clinical data using photon absorptiometry. Ann Intern Med 112:96-101
12. Zweig MH, Campbell G (1993) Receiver-operating characteristic (ROC) plots: a fundamental tool in clinical medicine. Clin Chem 39:561-577
13. Diaz-Curiel M, Castro N (1992) Bone mineral density in the Spanish population measured by dual X-ray absorptiometry (DEXA). (abstract) Bone Miner, 17(suppl 1):133
14. WHO Study Group (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: report of a WHO study group. WHO technical report series; 843, Geneva, Switzerland, p 129
15. Lee MS, Kim SY, Lee MC, Cho BY, Lee HK, Koh CS, Min HK (1990) Negative correlation between the change in bone mineral density and serum osteocalcin in patients with hyperthyroidism. J Clin Endocrinol Metab 70:766-770
16. Diamond T, Vine J, Smart R, Butler P (1994) Thyrotoxic bone disease in women: a potentially reversible disorder. Ann Intern Med 120:8-11
17. Cumings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, Cauley J, Black D, Vogt TM (1995) Risk factors for hip fracture in white women. New Engl J Med 332:767-772
18. Garnero P, Gineyts P, Riou JP, Delmas PD (1994) Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease. J Clin Endocrinol Metab 3:780-785
19. Jodar E, Muñoz-Torres M, Quesada M, Luna JD, Olea N, Escobar-Jiménez F (1996) Utility of new markers of bone turnover in hyperthyroid patients (Abstract). Osteoporosis Int 29(suppl 1):279
20. Cooper DS, Kaplan MM, Gigway EC, Maloof F, Daniel GH (1979) Alkaline phosphatase isoenzyme patterns in hyperthyroidism. Ann Intern Med 90:164-168
21. Mosekilde L, Ericksen EF, Charles P (1990) Effects of thyroid hormones on bone and mineral metabolism. Endocrinol Metab Clin North Am 19:35-63
22. Langdahl BL, Loft AGT, Ericksen EF, Mosekilde L, Charles P (1996) Bone mass, bone turnover, body composition, and calcium homeostasis in former hyperthyroid patients treated by combined medical therapy. Thyroid 6:161-168
23. Kroger H, Tuppurainen M, Honkanen R, Alhava E, Saarikoski S (1994) Bone mineral density and risk factors for osteoporosis: a population-based study of 1600 perimenopausal women. Calcif Tissue Int 55:1-7